Figure 1 (Fondaparinux Fig1)
Fondaparinux Sodium Injection, Solution
Product Images NDC 55150-232
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 32 technical images submitted to the FDA as part of the official labeling for Fondaparinux Sodium (NDC 55150-232). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Eugia Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure B. (Fondaparinux Fig10)
Figure C. (Fondaparinux Fig11)
Figure D. (Fondaparinux Fig12)
Figure E. (Fondaparinux Fig13)
Figure F. (Fondaparinux Fig14)
Figure G. (Fondaparinux Fig15)
Package Label-principal Display Panel (2.5 mg per 0.5 mL)
Auromedics Pharma LLC distributes Fondaparinux Sodium Injection, USP, a prescription drug with NDC code 55150-230-00. It is made in India under code TS/DRUGS/13/2010 and its batch number is P1419216.*
Package Label-principal Display Panel (2.5 mg per 0.5 mL)
This text appears to be a mixture of medical jargon, including medication names, dosages, and recommendations, as well as codes, addresses, and manufacturer details. It seems to describe a medication called Fondaparinux Sodium Injection, USP that comes in 2.5 mg per 0.5 mL single-dose prefilled syringes. The package includes an automatic needle protection system and a patient information leaflet in the carton. It is distributed by AuroMedics Pharma LLC and made in India. The text also lists a pharmacist's recommendation to dispense 2x0.5mL single-dose to a patient.*
Package Label-principal Display Panel (2.5 mg per 0.5 mL)
This is a description of the drug Fondaparinux in the form of a single-dose, prefilled syringe with an automatic needle protection system for subcutaneous injection. Each syringe contains 2.5 mg of Fondaparinux Sodium Injection, USP, and the recommended dose is 2.5 g subcutaneous injection. It is stored at 20°to 25°C (68° 1o 77°F) and packaged with a Patient Information Leaflet. The company distributing the drug in the United States is AuroMedics Pharma LLC.*
Package Label-principal Display Panel (5 mg per 0.4 mL)
This is a product description for Fondaparinux Sodium Injection, USP distributed by AuroMedics Pharma LLC in E. Windsor, NJ. The product is only available with a prescription and has a National Drug Code (NDC) of 55150-231-00. The product is manufactured in India and has a code of TS/DRUGS/13/2010 and P1419218.*
Figure 2 (Fondaparinux Fig2)
Package Label-principal Display Panel (5 mg per 0.4 mL)
This is a description of Fondaparinux Sodium Injection, USP, which is a medication dispensed using single-dose, pre-filled syringes. The syringes are affixed with an automatic needle protection system for subcutaneous injection. The medication is made in India and distributed by AuroMedics Pharma LLC, and each syringe contains 5mg per 0.4 mL of Fondaparinux Sodium Injection, USP. The packaging does not include patient information leaflets and bears the NDC 55150-231-02 and code TSDRUGS/1372010.*
Package Label-principal Display Panel (5 mg per 0.4 mL)
Fondaparinux Sodium Injection, USP, is a medication administered through a subcutaneous injection using single-dose, prefilled syringes. Each syringe contains 5 mg of fondaparinux sodium and is affixed with an automatic needle protection system. It is recommended to store this medication at 20° to 25°C, and pharmacists are directed to dispense it with a patient information leaflet. The medication is distributed by AuroMedics Pharma LLC, manufactured in India, and is NDC 55150-231-10.*
Package Label-principal Display Panel (7.5 mg per 0.6 mL)
This is a description of a medication called "Fondaparinux Sodium Injection, USP." It is distributed by AuroMedics Pharma LLC located in E. Windsor, NJ, and made in India. Moreover, the medication is available only with a prescription which is indicated by the text "Rxonly" before the National Drug Code (NDC) 55150-232-00. The other alphanumeric codes on the label are "Code: TS/DRUGS/13/2010" and "P1419219."*
Package Label-principal Display Panel (7.5 mg per 0.6 mL)
This text appears to be an image of a pharmaceutical product label. The product is Fondaparinux Sodium Injection, available in prefilled syringes containing 5 mg or 7.5 mg per 0.6 mL. The syringes are for subcutaneous use and have an automatic needle protection system. The label includes the NDC code, dosage information, and contact information for AuroMedics Pharma LLC, the distributor of the product.*
Package Label-principal Display Panel (7.5 mg per 0.6 mL)
This is a description of a pharmaceutical product called Fondaparinux Sodium Injection, USP, which is designed for subcutaneous injection. It comes in prefilled syringes that contain 7.5 mg of the product in 0.6 mL of saline solution, and the syringes are affixed with an automatic needle protection system. The recommended dose is 7.5 mg once a day. The product is distributed by AuroMedics Pharma LLC and should be stored at 20° to 25°C. The provided code is TSDRUGS/1312010, and the NDC number is 55150-232-10. The package contains 10 single-dose syringes. No additional information is provided.*
Package Label-principal Display Panel (10 mg per 0.8 mL)
This is a description of a medication called Fondaparinux Sodium. It is an injection, distributed by a company called AuroMedics Pharma LLC in E. Windsor, NJ. It is made in India and has a code of TS/DRUGS/13/2010 and NDC 55150-233-00.*
Package Label-principal Display Panel (10 mg per 0.8 mL)
This is a description of a medication in the form of two 0.8mL single-dose prefilled subcutaneous syringes of Fondaparinux Sodium Injection USP, with an automatic needle protection system affixed. The pharmacist is instructed to dispense without patient information the leaflet provided in the carton. The medication is distributed by AuroMedics Pharma LLC and is made in India. There is some gibberish text at the beginning and end of the provided text.*
Package Label-principal Display Panel (10 mg per 0.8 mL)
Fondaparinux Sodium Injection is a single-dose, prefilled syringe used for subcutaneous injection containing 10 mg of fondaparinux sodium USP. The syringe is affixed with an automatic needle protection system and comes in a pack of 10. It is recommended to store it at 20°C to 25°C. The product is distributed by AuroMedics Pharma LLC, made in India, and the container closure is not made with natural rubber. Patient information leaflet is provided in the carton.*
Package Label-principal Display Panel (2.5 mg per 0.5 mL)
This is a description of a medication called Fondaparinux, which is administered via a single-use prefilled syringe with an automatic needle protection system for subcutaneous injection, containing 25g of fondaparinux sodium USP in 0.5 mL of a sterile and preservative-free solution of sodium chloride and water for injection. The recommended dose is 2.5 mg per day and storage should be between 20-25°C (68-77°F). It does not contain hydrochloric acid or sodium hydroxide, and the pharmacist should dispense it with the patient information leaflet provided in the carton. The medication is produced by PR AUROMEDICS in India.*
Package Label-principal Display Panel (5 mg per 0.4 mL)
This is a description of a medication called Fondaparinux. It is a single dose, pre-filled syringe that features an automatic needle protection system and is intended for subcutaneous injection. Each syringe contains 5mg of the medication in a 0.4ml solution of fondaparinux sodium. The recommended dosage is a 5mg subcutaneous injection once a day. The medication should be stored at room temperature (20-25°C). The medication is distributed by AuroMedics Pharma LLC. Instructions and warnings should be provided to patients with the medication.*
Figure 3 (Fondaparinux Fig3)
Package Label-principal Display Panel – 7.5 mg Per 0.6 mL (Prefilled Syringe Blister Pack Label)
Fondaparinux Sodium Injection is a prescription drug in the form of a single dose, prefilled syringe, affixed with an automatic needle protection system. It is intended to be administered subcutaneously, containing 7.5mg of fondaparinux sodium in 0.6mL of a solution consisting of sodium chloride and water for injection. The recommended dose is 7.5mg subcutaneous injection, once a day. The drug is manufactured and distributed by AuroMedics Pharmaceuticals. Storage temperature should be between 20°C to 25°C. Patient information leaflet is available inside the carton.*
Package Label-principal Display Panel – 10 mg Per 0.8 mL (Prefilled Syringe Blister Pack Label)
Fondaparinux Sodium Injection is a prescription drug that comes in a prefilled syringe with a needle protection system. It is used for subcutaneous injection and contains 10mg of fondaparinux sodium USP (equivalent to 8.3mg fondaparinux) in 0.8 mL of a sterile, preservative-free solution of sodium chloride and water. The recommended dose is 0.5mg subcutaneously once a day. The medication should be stored at a temperature of 20°C to 25°C. Patient information is provided in the carton. This drug is distributed by AuroMedics Pharma LLC in East Windsor, NJ.*
Figure 4 (Fondaparinux Fig4)
Figure 5 (Fondaparinux Fig5)
Figure 6 (Fondaparinux Fig6)
Syringe Before Use (Fondaparinux Fig7)
Syringe After Use (Fondaparinux Fig8)
Figure A. (Fondaparinux Fig9)
Fondaparinux Sodium Chemical Structure (Fondaparinux Str)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
